AR203646A1 - Procedimiento para preparar una cepa de adenovirus bovino termosensible y sustancialmente no patogeno - Google Patents

Procedimiento para preparar una cepa de adenovirus bovino termosensible y sustancialmente no patogeno

Info

Publication number
AR203646A1
AR203646A1 AR25373674A AR25373674A AR203646A1 AR 203646 A1 AR203646 A1 AR 203646A1 AR 25373674 A AR25373674 A AR 25373674A AR 25373674 A AR25373674 A AR 25373674A AR 203646 A1 AR203646 A1 AR 203646A1
Authority
AR
Argentina
Prior art keywords
pathogenic
preparing
procedure
substantially non
bovine adenovirus
Prior art date
Application number
AR25373674A
Other languages
English (en)
Spanish (es)
Original Assignee
Rit Rech Ind Therapeut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rit Rech Ind Therapeut filed Critical Rit Rech Ind Therapeut
Application granted granted Critical
Publication of AR203646A1 publication Critical patent/AR203646A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10111—Atadenovirus, e.g. ovine adenovirus D
    • C12N2710/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/813—Viral vaccine for bovine species, e.g. cattle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AR25373674A 1973-05-14 1974-05-14 Procedimiento para preparar una cepa de adenovirus bovino termosensible y sustancialmente no patogeno AR203646A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36021973A 1973-05-14 1973-05-14
US05438503 US3927208A (en) 1973-05-14 1974-01-31 Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them

Publications (1)

Publication Number Publication Date
AR203646A1 true AR203646A1 (es) 1975-09-30

Family

ID=27000811

Family Applications (1)

Application Number Title Priority Date Filing Date
AR25373674A AR203646A1 (es) 1973-05-14 1974-05-14 Procedimiento para preparar una cepa de adenovirus bovino termosensible y sustancialmente no patogeno

Country Status (13)

Country Link
US (1) US3927208A (xx)
JP (1) JPS5710845B2 (xx)
AR (1) AR203646A1 (xx)
CA (1) CA1039186A (xx)
CH (1) CH589141A5 (xx)
DD (1) DD112663A5 (xx)
DE (2) DE2463143C2 (xx)
ES (1) ES426215A1 (xx)
FR (1) FR2229398B1 (xx)
GB (1) GB1430711A (xx)
HU (1) HU169758B (xx)
IE (1) IE40924B1 (xx)
NL (1) NL7406407A (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225582A (en) * 1979-03-08 1980-09-30 The University Of Illinois Foundation Vaccine for equine rhinopneumonitis
US4618493A (en) * 1982-10-13 1986-10-21 Smithkline-Rit Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them
NZ224422A (en) * 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
US6398774B1 (en) 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system
US7678087B2 (en) * 1999-09-29 2010-03-16 Heska Corporation Equine intranasal delivery system
DK2898890T3 (da) 2010-03-31 2019-11-25 Stabilitech Biopharma Ltd Stabilisering af viruspartikler
AU2011234264B2 (en) 2010-03-31 2016-02-04 Stabilitech Ltd Excipients for stabilising viral particles, polypeptides or biological material
ES2708989T3 (es) 2010-03-31 2019-04-12 Stabilitech Biopharma Ltd Método de conservación de adyuvantes de alumbre y vacunas potenciadas con alumbre
GB201117233D0 (en) 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
US10581081B1 (en) * 2019-02-01 2020-03-03 Chang Chun Petrochemical Co., Ltd. Copper foil for negative electrode current collector of lithium ion secondary battery

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3052606A (en) * 1958-08-30 1962-09-04 Behringwerke Ag Viral mutation with nitrites

Also Published As

Publication number Publication date
AU6888474A (en) 1975-11-13
CA1039186A (en) 1978-09-26
JPS5710845B2 (xx) 1982-03-01
CH589141A5 (xx) 1977-06-30
JPS5052226A (xx) 1975-05-09
IE40924L (en) 1974-11-14
DD112663A5 (xx) 1975-04-20
HU169758B (xx) 1977-02-28
ES426215A1 (es) 1976-11-16
FR2229398B1 (xx) 1978-03-24
DE2423129C2 (de) 1985-01-10
GB1430711A (en) 1976-04-07
IE40924B1 (en) 1979-09-12
DE2423129A1 (de) 1974-12-05
US3927208A (en) 1975-12-16
FR2229398A1 (xx) 1974-12-13
DE2463143C2 (de) 1985-04-11
NL7406407A (xx) 1974-11-18

Similar Documents

Publication Publication Date Title
ES211434Y (es) Una matriz para uso en la fabricacion de elementos de inte-rcambio de color.
CA1013673A (en) Enterically active microcapsule
NO137278C (no) Ikke-ioniske celluloseetere og fremgangsm}te til deres fremstilling
AR208397A1 (es) Procedimiento para la elaboracion de compuestos de 1-piridiloxi-2-hidroxi-3-amino-propano1-piraziniloxi-2-hidroxi-3-amino-propano y 1-pirimidiniloxi-2-hidroxi-3-amino-propan
AR203646A1 (es) Procedimiento para preparar una cepa de adenovirus bovino termosensible y sustancialmente no patogeno
AR193864A1 (es) Una composicion de material adecuada para la implantacion in vivo
AR197635A1 (es) Procedimiento para la preparacion de una composicion resistente a la soldadura, fotocurable
IT1056027B (it) Pallette di grafite e relativo procedimento di applicazione
AR203038A1 (es) Modulador delta
AR198389A1 (es) Procedimiento para la preparacion de una enzima capaz de degradar al cariogenano
AR194585A1 (es) Una preparacion de material colorante y un procedimiento para su preparacion
IT946568B (it) Modulatore delta perfezionato
AR210453A1 (es) Procedimiento para la preparacion de una 6-alfa-dioxitetraciclina
AR199944A1 (es) Procedimiento para la preparacion de 2-(fenoxialquiltio)-5-nitroimidazoles y congeneres
IT1017511B (it) Carica a propellente solido e procedimento per la sua fabbri cazione
IT971924B (it) Miglioramenti relativi a rilega ture mobili per periodici e simili
AR199648A1 (es) Procedimiento para la preparacion de oxazoles 2,4,5-trisustituidos
AU463328B2 (en) New orthopedic cast material
IT1006439B (it) Matrice per la stampa planografi ca e procedimento per la sua pro duzione
AR195596A1 (es) Nuevos colorantes de azo-pirazolio y procedimiento para su preparacion
AR201878A1 (es) Procedimiento para preparar una vacuna inmunizante y no patogena
AR196038A1 (es) Nuevos acidos naftalimid-4,5-dicarboxilicos y procedimiento para su preparacion
AR193861A1 (es) Microcapsulas y procedimiento para su obtencion
AR200309A1 (es) Procedimiento para la elaboracion de nuevas 6-aza-3h-1,4-benzodiazepinas y 6-aza-1,2-dehidro-3h-1,4-benzodiazepinas
YU274174A (en) Bearing for bridges and similar constructions